Pseudomonas aeruginosa infection exacerbates elastase induced lung damage: characterisation of a novel murine two-hit model of pulmonary infection

铜绿假单胞菌感染加剧弹性蛋白酶诱导的肺损伤:一种新型小鼠肺部感染二次打击模型的特征分析

阅读:1

Abstract

BACKGROUND: Pulmonary bacterial infections remain a hallmark of a range of respiratory diseases including Cystic Fibrosis (CF), Chronic Obstructive Pulmonary Disease (COPD) and non-CF bronchiectasis (NCFBE). Chronic persistent infections in the lung including P. aeruginosa are characterised by periods of stability punctuated by acute pulmonary exacerbations (PExs). Whilst animal infection models can reliably replicate acute and stable chronic infections, none currently replicate appropriate 'acute-on-chronic' pathophysiological backgrounds required to model PExs. Here, we aimed to establish a novel two-hit model of chronic P. aeruginosa infection where animals were first subjected to elastase challenge inducing pulmonary inflammation and injury reflective of the CF/COPD lung and subsequently infected with P. aeruginosa, utilised for its commonality across PExs in CF, COPD and NCFBE patients. METHODS: Mice were challenged with 2 mg/kg Porcine Pancreatic Elastase (PPE) on days 1, 4 and 7 before infection with 1 × 10(6) cfu/mouse P. aeruginosa strain RP73, 3 days post final PPE challenge. 2-, 5-, and 7- days post infection, both pulmonary microbiological and inflammatory readouts were quantified. RESULTS: PPE induced significant pulmonary neutrophil recruitment alongside structural markers of lung injury characteristic of CF, COPD and NCFBE. In the two-hit cohort, bacterial clearance following P. aeruginosa infection was significantly impaired in animals first subjected to repeated elastase challenge. This was accompanied by exacerbated neutrophilic recruitment and activation, accelerating PPE induced lung damage characteristic of PExs. CONCLUSIONS: Taken together, this two-hit model of pulmonary infection with P. aeruginosa following PPE induced lung injury replicates key pathophysiological changes consistent with PExs relevant to CF, COPD and NCFBE patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。